BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27288452)

  • 1. A reduction in Drp1-mediated fission compromises mitochondrial health in autosomal recessive spastic ataxia of Charlevoix Saguenay.
    Bradshaw TY; Romano LE; Duncan EJ; Nethisinghe S; Abeti R; Michael GJ; Giunti P; Vermeer S; Chapple JP
    Hum Mol Genet; 2016 Aug; 25(15):3232-3244. PubMed ID: 27288452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
    Girard M; Larivière R; Parfitt DA; Deane EC; Gaudet R; Nossova N; Blondeau F; Prenosil G; Vermeulen EG; Duchen MR; Richter A; Shoubridge EA; Gehring K; McKinney RA; Brais B; Chapple JP; McPherson PS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1661-6. PubMed ID: 22307627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Criscuolo C; Procaccini C; Meschini MC; Cianflone A; Carbone R; Doccini S; Devos D; Nesti C; Vuillaume I; Pellegrino M; Filla A; De Michele G; Matarese G; Santorelli FM
    J Neurol; 2015 Dec; 262(12):2755-63. PubMed ID: 26530509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsin.
    Duncan EJ; Larivière R; Bradshaw TY; Longo F; Sgarioto N; Hayes MJ; Romano LEL; Nethisinghe S; Giunti P; Bruntraeger MB; Durham HD; Brais B; Maltecca F; Gentil BJ; Chapple JP
    Hum Mol Genet; 2017 Aug; 26(16):3130-3143. PubMed ID: 28535259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Transcriptome Analysis in ARSACS KO Cell Model Reveals a Role of Sacsin in Autophagy.
    Morani F; Doccini S; Sirica R; Paterno M; Pezzini F; Ricca I; Simonati A; Delledonne M; Santorelli FM
    Sci Rep; 2019 Aug; 9(1):11878. PubMed ID: 31417125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ARSACS disease protein sacsin controls lysosomal positioning and reformation by regulating microtubule dynamics.
    Francis V; Alshafie W; Kumar R; Girard M; Brais B; McPherson PS
    J Biol Chem; 2022 Sep; 298(9):102320. PubMed ID: 35933016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration.
    Bagaria J; Bagyinszky E; An SSA
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into SACS pathological attributes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)☆.
    Aly KA; Moutaoufik MT; Zilocchi M; Phanse S; Babu M
    Curr Opin Chem Biol; 2022 Dec; 71():102211. PubMed ID: 36126381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New practical definitions for the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Pilliod J; Moutton S; Lavie J; Maurat E; Hubert C; Bellance N; Anheim M; Forlani S; Mochel F; N'Guyen K; Thauvin-Robinet C; Verny C; Milea D; Lesca G; Koenig M; Rodriguez D; Houcinat N; Van-Gils J; Durand CM; Guichet A; Barth M; Bonneau D; Convers P; Maillart E; Guyant-Marechal L; Hannequin D; Fromager G; Afenjar A; Chantot-Bastaraud S; Valence S; Charles P; Berquin P; Rooryck C; Bouron J; Brice A; Lacombe D; Rossignol R; Stevanin G; Benard G; Burglen L; Durr A; Goizet C; Coupry I
    Ann Neurol; 2015 Dec; 78(6):871-86. PubMed ID: 26288984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics.
    Gentil BJ; Lai GT; Menade M; Larivière R; Minotti S; Gehring K; Chapple JP; Brais B; Durham HD
    FASEB J; 2019 Feb; 33(2):2982-2994. PubMed ID: 30332300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of defects in the sacsin HEPN domain responsible for autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
    Kozlov G; Denisov AY; Girard M; Dicaire MJ; Hamlin J; McPherson PS; Brais B; Gehring K
    J Biol Chem; 2011 Jun; 286(23):20407-12. PubMed ID: 21507954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SACS mutation in autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Sánchez MG; Pérez JE; Pérez MR; Redondo AG
    J Neurol Sci; 2015 Nov; 358(1-2):475-6. PubMed ID: 26344561
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel SACS p.Pro4154GlnfsTer20 mutation in a family with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Samanci B; Gokalp EE; Bilgic B; Gurvit H; Artan S; Hanagasi HA
    Neurol Sci; 2021 Jul; 42(7):2969-2973. PubMed ID: 33559790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACS.
    Nethisinghe S; Abeti R; Kesavan M; Wigley WC; Giunti P
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Larivière R; Gaudet R; Gentil BJ; Girard M; Conte TC; Minotti S; Leclerc-Desaulniers K; Gehring K; McKinney RA; Shoubridge EA; McPherson PS; Durham HD; Brais B
    Hum Mol Genet; 2015 Feb; 24(3):727-39. PubMed ID: 25260547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research advance on the pathogenesis of autosomal recessive spastic ataxia of Charlevoix-Saguenay].
    Fu R; Ding M; Lu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Jan; 40(1):121-124. PubMed ID: 36585015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Sacsin Turnover in Patients With ARSACS: Implications for Molecular Diagnosis and Pathogenesis.
    Longo F; De Ritis D; Miluzio A; Fraticelli D; Baets J; Scarlato M; Santorelli FM; Biffo S; Maltecca F
    Neurology; 2021 Dec; 97(23):e2315-e2327. PubMed ID: 34649874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional studies of retinal degeneration as a clinical presentation of SACS-related disorder.
    Blumkin L; Bradshaw T; Michelson M; Kopler T; Dahari D; Lerman-Sagie T; Lev D; Chapple JP; Leshinsky-Silver E
    Eur J Paediatr Neurol; 2015 Jul; 19(4):472-6. PubMed ID: 25819952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human iPSC line from a patient with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) caused by mutation in SACSIN gene.
    Arellano CM; Vilches A; Clemente E; Pascual-Pascual SI; Bolinches-Amorós A; Castro AA; Espinos C; Rodriguez ML; Jendelova P; Erceg S
    Stem Cell Res; 2018 Aug; 31():249-252. PubMed ID: 30144656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacsinopathies: sacsin-related ataxia.
    Takiyama Y
    Cerebellum; 2007; 6(4):353-9. PubMed ID: 17853117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.